Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis
Yan Li, Xueyan Liang, Huijuan Li, Xiaoyu Chen
Topics & Concepts
MedicineIpilimumabNivolumabInternal medicineRegimenAdverse effectOncologyRandomized controlled trialPembrolizumabMelanomaCancerImmunotherapyCancer researchCancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and ManagementMelanoma and MAPK Pathways